A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

NCT00424294 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped See Detailed Description field

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: CP-195,543
DRUG: celecoxib
DRUG: Methotrexate

Sponsor

Pfizer